Protaryx Medical is developing a transseptal access device designed to facilitate the crossing of the atrial septum, enhancing workflow efficiency for catheter-based, minimally invasive left heart interventions. This technology addresses the challenge of reliable access to the left atrium, enabling streamlined delivery of therapeutic devices without the need for exchange.
Funding
$8.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Gaining reliable access to the left atrium during minimally invasive, catheter-based cardiac procedures can be challenging, often requiring multiple device exchanges and increasing procedural complexity. Current transseptal access methods may lack precise steering capabilities and can potentially cause trauma to the atrial septum.
Solution
Protaryx Medical is developing a novel transseptal access device designed to streamline left heart interventions by facilitating efficient and atraumatic crossing of the atrial septum. The device aims to improve workflow efficiency by enabling direct delivery of therapeutic devices to the left atrium without the need for guidewire or catheter exchange. Its design focuses on providing enhanced maneuverability and clear visualization during the transseptal puncture.
Target Audience
The primary target audience includes interventional cardiologists and electrophysiologists performing left atrial procedures such as mitral valve repair, left atrial appendage closure, and atrial fibrillation ablation.
Features
- Independently steerable tip for precise navigation within the right atrium.
- Atraumatic tip design to minimize the risk of damage to the atrial septum during puncture and crossing.
- Highly echogenic materials for enhanced visualization under intracardiac echocardiography (ICE).
- ZERO Exchange compatibility, allowing direct delivery of left atrial therapy devices without guidewire or catheter exchange.